Preview Mode Links will not work in preview mode

BioTalk with Rich Bendis


Feb 7, 2022

Geoffrey Lynn, SVP, Synthetic Immunotherapies, Vaccitech, joins BioTalk to discuss his career from NIH, to CEO of Avidea, to their merger with Vaccitech.